Sudeep Pharma Ltd. (SUDEEPPHRM.NS)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in INRTTM unavailable| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | INR m | - | - | - | - | - | - | - | - |
| Operating profit | INR m | - | |||||||
| Net profit | INR m | - | - | - | - | - | - | - | - |
| EPS reported | INR | - | |||||||
| Operating cashflow per share | INR | - | |||||||
| Capex per share | INR | - | |||||||
| FCF per share | INR | - | |||||||
| Free cash flow | INR m | - | |||||||
| Net debt | INR m | - | |||||||
| Book value equity | INR m | - | |||||||
| Book value per share | INR | - | |||||||
| Number of shares | m | - | |||||||
| DPS (TTM paid) | INR | - |
Financial summary
Financials in INRTTM unavailable| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | |||||||
| P/B LTM | x | - | |||||||
| P/S LTM | x | - | |||||||
| P/FCF LTM | x | - | |||||||
| EV/EBITDA LTM | x | - | |||||||
| EV/Sales LTM | x | - | |||||||
| Earnings Yield LTM | % | - | |||||||
| FCF Yield | % | - | |||||||
| Quality | |||||||||
| ROE | % | - | |||||||
| ROIC | % | - | |||||||
| Operating margin | % | - | |||||||
| Gross margin | % | - | |||||||
| FCF/Sales | % | - | |||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | |||||||
| Sales Growth YoY | % | - | |||||||
| Net Income Growth YoY | % | - | |||||||
| FCF Growth | % | - | |||||||
| Operating Profit Growth | % | - | |||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | - | |||||||
| Dividend Growth | % | - | |||||||
| Payout Ratio | % | - | |||||||
| FCF/Debt | x | - | |||||||
| Net Debt/EBITDA | x | - | |||||||
| EBIT/Net interest | x | - | |||||||
| Net debt/market cap | % | - | |||||||
| Net debt/Equity | x | - | |||||||
| Gross debt/equity | x | - | |||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Established in 1989 and headquartered in Vadodara, India, Sudeep Pharma Limited specializes in the manufacturing and distribution of excipients and unique ingredients. The company serves the pharmaceutical, food, and nutrition sectors, with a market reach extending across the United States, Europe, the United Kingdom, and Latin America. Its product range includes essential mineral salts such as calcium, zinc, iron, potassium, magnesium, sodium, and copper, which are vital for a variety of health-focused applications. Sudeep Pharma also provides calcium carbonate, utilized as an active pharmaceutical ingredient in diverse therapeutic contexts. Furthermore, the company develops and supplies advanced nutrient formulations, including micronutrient premixes, encapsulated ingredients, liposomal and spray-dried formats, granulated minerals, and triturated blends. These innovative solutions are designed for applications in functional foods, dietary supplements, infant and clinical nutrition, fast-moving consumer goods, and convenience food products. Beyond production, Sudeep Pharma's extensive operations encompass the development, trade, import, export, and processing of a broad spectrum of pharmaceuticals, nutraceuticals, food ingredients, and vitamin/mineral blends for human and animal nutrition, alongside other chemical and healthcare products.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Sudeep Pharma Ltd. (SUDEEPPHRM.NS)
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Established in 1989 and headquartered in Vadodara, India, Sudeep Pharma Limited specializes in the manufacturing and distribution of excipients and unique ingredients. The company serves the pharmaceutical, food, and nutrition sectors, with a market reach extending across the United States, Europe, the United Kingdom, and Latin America. Its product range includes essential mineral salts such as calcium, zinc, iron, potassium, magnesium, sodium, and copper, which are vital for a variety of health-focused applications. Sudeep Pharma also provides calcium carbonate, utilized as an active pharmaceutical ingredient in diverse therapeutic contexts. Furthermore, the company develops and supplies advanced nutrient formulations, including micronutrient premixes, encapsulated ingredients, liposomal and spray-dried formats, granulated minerals, and triturated blends. These innovative solutions are designed for applications in functional foods, dietary supplements, infant and clinical nutrition, fast-moving consumer goods, and convenience food products. Beyond production, Sudeep Pharma's extensive operations encompass the development, trade, import, export, and processing of a broad spectrum of pharmaceuticals, nutraceuticals, food ingredients, and vitamin/mineral blends for human and animal nutrition, alongside other chemical and healthcare products.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free